The market for radial artery compression devices is seeing huge growth because of the rising inclination for minimally invasive methodology. As additional medical care suppliers and patients perceive the advantages of radial access for different interventions, the interest for compression devices planned explicitly for the radial artery has flooded.
The worldwide predominance of cardiovascular sicknesses is on the ascent, driving the interest for creative clinical devices. Radial artery compression devices assume a vital part in post-procedural consideration after cardiovascular mediations performed through radial access. The rising frequency of conditions like coronary artery illness has pushed the market forward.
Radial artery access offers a few benefits over customary femoral artery access, including decreased draining inconveniences, quicker recuperation, and further developed comfort. As awareness of these advantages develops among both medical services experts and patients, the market for radial artery compression devices is supposed to extend.
The pattern towards short term or walking care for different operations has affected the reception of radial artery access. Radial mediations consider more limited medical clinic stays and faster recuperation times, lining up with the more extensive medical care industry's emphasis on short term administrations and smart medical care delivery.
The emphasis on patient security in medical services rehearses has prompted expanded examination of post-procedural consideration. Radial artery compression devices assume a vital part in limiting complexities like dying, hematoma development, and nerve injury, lining up with the worldwide medical care center around working on understanding results and security.
Radial Artery Compression Devices Market Size was valued at USD 0.54 Billion in 2023. The Global Radial Artery Compression Devices industry is projected to grow from USD 0.58 Billion in 2024 to USD 1.06 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.05% during the forecast period (2024 - 2032).
For instance, in February 2024, Terumo Medical Corporation opened a new manufacturing facility in Caguas, Puerto Rico, to expand production and meet the growing demand for Angio-Seal vascular closure devices. Increasing the number of devices available in the market can boost product volume through this expansion of the manufacturing facility so that it is expected to meet the growing requirement of the devices as well as drive this market.
TZ Medical introduced the Roc Band as a new radial hemostasis band designed to maintain patency in June 2023. This device offers better hemostasis and optimizes the time for patients to recover.
On April 26th, 2023, medical device company Terumo Europe N.V. announced its latest clinical trial: Eluting Coronary Stent Systems in Patients with Complex PCI Ultimaster Nagomi Sirolimus Ultimaster Nagomi It helps increase coronary artery repair rate in CVD patients.
Merit Medical Sytems launched the PreludeSYNC EZ Radial Compression Device in the United States in November 2022. The cinch-style wristband is unique and helps with two-handed placement under control, thereby achieving access site patent hemostasis.
GE Healthcare brings forward innovations aimed at coordinating cardiac care during the September 2022 Transcatheter Cardiac Therapy (TCT2022) Conference, CRF Annual Scientific Meeting by Cardiology Research Foundation (CRF), one of the world’s leading educational conferences for participating cardiologists.
Commercial cases were conducted by Medical Ingenuities in March 2022 on a transformative radial hemostasis band system known as PH Band that worked to achieve patent hemostasis at the United States’ Lakewood Ranch Medical Center. In comparison to other radial bands, all these cases were successful and demonstrated additional benefits associated with the PH Band.
This is done through a hydrophilic polymer that bleeds while potassium ferrate collects blood solids and proteins, forming a seal on the skin, which, if extended, can cause problems such as radial artery occlusion and hemorrhagic disease.
The radial artery compression device is one of the major segment of the artery compression device market. Radial artery compression devices are expected to grow at a significant growth rate. The major factors influencing the growth of the market include; increasing growth in technological advancement in the field of medical devices, rising economic growth, increasing geriatric devices, increasing cardiovascular disorders, and others.
Cardiovascular disorders are heart conditions that include diseased vessels, structural problems, and blood clots. Radial artery compression devices are used to assist hemostasis of the radial artery after a transradial procedure. Transradial cardiac catheterization is a technique used for the treatment and diagnosis of certain heart conditions.
The increasing cardiovascular rate is eventually driving the growth of the radial artery compression devices market. For instance, according to the American Heart Association, in 2014, around 31% of the deaths in the US were due to cardiovascular disorders. Similarly, as per the American Heart Association, around USD 555 billion was spent in the Americas for the treatment of cardiovascular disorders. Additionally, according to the European Heart Network, in 2015, there was 85 million population living with cardiovascular disorders in Europe. The high occurrence rate of cardiovascular diseases (CVD) globally relates to the high prevalence of well-known risk factors such as hypertension, smoking, dyslipidemia (high cholesterol), diabetes, obesity, and unhealthy lifestyle. The US tops the chart as the most obese country in North America with 36.2% of its total population having a body mass index of over 30.0. Thus, the increasing occurrences of obesity are likely to fuel the cardiovascular patient pool indirectly, thus spurring the demand for the market.
The radial artery compression devices market has been segmented into product, usage, and end user.
Based on product, the market is segmented into band/strap based devices, knob-based devices, plate-based devices, others
On the basis of usage, the market is segmented into disposable devices, reusable devices
Based on end user, the radial artery compression devices market is segmented into hospitals, clinics, ambulatory centers, cath lab, and others.
The radial artery compression devices market, by region, has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The radial artery compression devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European radial artery compression devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The radial artery compression devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Radial Artery Compression Devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Regional Market Summary
Geographically, the Americas is anticipated to dominate the radial artery compression devices market owing to the presence of a huge cardiovascular disorders patient population, increasing adoption of advanced technology in the field of medical device, high healthcare expenditure, and the presence of major players in the region.
Europe is expected to hold the second largest position in the radial artery compression devices market.
Asia-Pacific is the fastest growing radial artery compression devices market owing to the increasing geriatric population, the presence of a huge patient pool and rapidly improving the technology.
The Middle East and Africa market for radial artery compression devices is expected to grow at a steady pace.
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)